Journal Article Summary
The article investigates the prevalence of aspirin resistance (AR) among patients who have experienced ischemic strokes and compares it to healthy individuals. This topic is significant because aspirin is commonly used to prevent recurrent strokes, and understanding AR could help improve treatment strategies for those at risk of stroke recurrence. Given that cerebrovascular diseases are a leading cause of death and disability worldwide, identifying factors that contribute to treatment failure is crucial for enhancing patient outcomes.
In this study, researchers evaluated 350 patients with a history of ischemic stroke who were on aspirin therapy, alongside 100 healthy controls. They used an optical platelet aggregation test to measure AR, finding that 7.4% of stroke patients and 4% of controls exhibited resistance. Notably, AR was linked to a higher rate of stroke recurrence among patients, with 46.2% of those with AR having experienced a previous stroke compared to 21.3% of those without AR. However, the study did not find a significant association between AR and common risk factors like smoking, diabetes, or high cholesterol.
The study has limitations, including its retrospective nature, which may affect the reliability of the findings regarding stroke recurrence. Patients and caregivers should be aware that while AR can complicate treatment with aspirin, the exact causes and implications are still being studied. It is essential for individuals on aspirin therapy, especially those with a history of strokes, to discuss their treatment and any concerns about AR with their healthcare providers to ensure optimal management and prevention strategies.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Roman-Gonzalez Alejandro, Naranjo Carlos Andrés, Cardona-Maya Walter D., Vallejo Dionis, Garcia Francisco, Franco Cesar, Alvarez Leonor, Tobón Luis Ignacio, et al.. Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia. Stroke Research and Treatment 2021. DOI: 10.1155/2021/9924710. PMID: 34094500. PMCID: PMC8164531.
Featured Pill Pals Product
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs --- Over The Counter
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over — Generic For Bayer Low Dose — Time Cap Labs — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
